Everyday Health to share content with Yahoo! Health

Share this article:
Michael Keriakos
Michael Keriakos

Waterfront Media's Everyday Health Network announced today that it will provide content to Yahoo! Health under a new partnership.

The deal will provide Yahoo! Health with content from several of the Everyday Health Network sites, including WhatToExpect.com, a parenting and pregnancy site, and SouthBeathDiet.com, among others.

“We're very excited,” Mike Keriakos, president and co-founder of Waterfront Media, told MM&M. “Yahoo! Health is powering a substantial amount of content,” said Keriakos, noting that the company hopes the partnership will translate into unique viewers on the Everyday Health Network portfolio of sites—in numbers “significantly north of a million,” according to Keriakos.

Yahoo! Health will have access to any current and future content provided by the Everyday Health Network, with attributions and links back to the relevant Waterfront Media sources, the company stated in a release.

Keriakos cited comScore numbers in support of Everyday Health's predominant position over WebMD, in terms of unique visitors—at least for the moment. “We're highly confident that we'll be ahead of WebMD during 4Q and 1Q,” said Keriakos, noting that he can't predict what kinds of acquisitions or other initiatives WebMD might roll out in order to compete for viewers.

Yahoo! Health is the sixth largest online health site, according to September 2008 comScore data.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.